3
Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0) Population CRP 1.0-2.9 mg/L, RR (95% CI) CRP > 3.0 mg/L, RR (95% CI) p for trend Women (patients, n=239; controls, n=469) 1.17 (0.69-2.00) 1.53 (0.89-2.62) 0.09 Men (patients, n=265; controls, n=529) 1.60 (1.09-2.34) 1.79 (1.14-2.83) 0.03 Men and women 1.44 (1.05-1.96) 1.68 (1.18-2.38) 0.008 *Adjusted for age, smoking status, month of blood sampling, parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index, diabetes, and hypertension; and in women only, also adjusted for fasting status at time of blood sampling and postmenopausal hormone therapy status.

Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Embed Size (px)

Citation preview

Page 1: Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Pai JK et al. N Engl J Med 2004; 351:2599-2610.

Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP<1.0 mg/L (RR=1.0)Population CRP 1.0-2.9

mg/L, RR (95% CI)

CRP >3.0 mg/L, RR (95% CI)

p for trend

Women (patients, n=239; controls, n=469)

1.17(0.69-2.00)

1.53(0.89-2.62)

0.09

Men (patients, n=265; controls, n=529)

1.60(1.09-2.34)

1.79(1.14-2.83)

0.03

Men and women 1.44(1.05-1.96)

1.68(1.18-2.38)

0.008

*Adjusted for age, smoking status, month of blood sampling, parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index, diabetes, and hypertension; and in women only, also adjusted for fasting status at time of blood sampling and postmenopausal hormone therapy status.

Page 2: Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Relative CHD risk by baseline CRP plasma levels, by quintiles relative to lowest quintile (RR=1.0)

Pai JK et al. N Engl J Med 2004; 351:2599-2610.

Quintiles by sex

Adjusted for case-matching criteria,* RR(95% CI)

Further adjusted for TC:HDL-C, BMI, other risk factors,** RR (95% CI)

Further adjusted for diabetes and hypertension, RR (95% CI)

Women      

•Quintile 2 •1.28•(0.74-2.23)

•1.17•(0.64-2.14)

•1.23•(0.66-2.32)

•Quintile 3 •1.03•(0.59-1.81)

•0.81•(0.43-1.52)

•0.89•(0.46-1.72)

•Quintile 4 •1.54•(0.91-2.63)

•1.17•(0.64-2.14)

•1.22•(0.65-2.30)

•Quintile 5 •2.18•(1.30-3.64)

•1.86•(1.00-3.46)

•1.61•(0.84-3.07)

—p for trend <0.001 0.008 0.08*Age, smoking status, month of blood sampling; in women only, also adjusted for fasting status at time of blood sampling.**Parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index (BMI); in women only, also adjusted for postmenopausal hormone therapy status.

Page 3: Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Relative CHD risk by baseline CRP plasma levels, by quintiles relative to lowest quintile (RR=1.0)

Pai JK et al. N Engl J Med 2004; 351:2599-2610.

Quintiles by sex

Adjusted for case-matching criteria,* RR(95% CI)

Further adjusted for TC:HDL-C, BMI, other risk factors,** RR (95% CI)

Further adjusted for diabetes and hypertension, RR (95% CI)

Men      

•Quintile 2 •1.81•(1.04-3.17)

•1.75•(0.97-3.14)

•1.75•(0.97-3.16)

•Quintile 3 •2.00•(1.15-3.50)

•1.83•(1.02-3.30)

•1.74•(0.96-3.15)

•Quintile 4 •2.74•(1.59-4.71)

•2.27•(1.26-4.09)

•2.14•(1.18-3.88)

•Quintile 5 •3.29•(1.91-5.65)

•2.73•(1.51-4.96)

•2.55•(1.40-4.65)

—p for trend <0.001 0.007 0.02

*Age, smoking status, month of blood sampling; in women only, also adjusted for fasting status at time of blood sampling.**Parental CHD history, alcohol intake, exercise activity level, total cholesterol/HDL cholesterol ratio, body mass index (BMI); in women only, also adjusted for postmenopausal hormone therapy status.